LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Citius Oncology (NASDAQ: CTOR)

Follow NASDAQ:CTOR Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ CTOR Citius Oncology
Mayersohn Joel David / director
12/12/2024
Buy
$1.07
250,000
$268K
250,000
NASDAQ CTOR Citius Oncology
Holuka Eugene Myron / director
12/12/2024
Buy
$1.07
125,000
$134K
125,000
NASDAQ CTOR Citius Oncology
HOLUBIAK MYRON Z / director, officer: Secretary
12/12/2024
Buy
$1.07
300,000
$321K
300,000
NASDAQ CTOR Citius Oncology
HOLUBIAK MYRON Z / director, officer: Secretary
12/12/2024
Buy
$1.07
50,000
$54K
50,000
NASDAQ CTOR Citius Oncology
Smith Robert Joseph / director
12/12/2024
Buy
$1.07
125,000
$134K
125,000
NASDAQ CTOR Citius Oncology
Webb Carol / director
12/12/2024
Buy
$1.07
125,000
$134K
125,000
NASDAQ CTOR Citius Oncology
Dutia Suren G / director
12/12/2024
Buy
$1.07
125,000
$134K
125,000
NASDAQ CTOR Citius Oncology
MCGRATH DENNIS M / director
12/12/2024
Buy
$1.07
125,000
$134K
125,000
NASDAQ CTOR Citius Oncology
Bartushak Jaime / officer: Chief Financial Officer
12/12/2024
Buy
$1.07
400,000
$428K
400,000
NASDAQ CTOR Citius Oncology
Mazur Leonard L / director, officer: Chief Executive Officer
12/12/2024
Buy
$1.07
800,000
$856K
800,000
NASDAQ CTOR Citius Oncology
Czuczman Myron / officer: Chief Medical Officer
12/12/2024
Buy
$1.07
400,000
$428K
400,000

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous